Post

New research · Ophthalmology
Ophthalmology and therapy · 4d
Cohort studyOphthalmology and therapy · 2026

Photodynamic Therapy in Central Serous Chorioretinopathy: Treatment Timing, Anatomical Response, and Recurrence in a Large Real-World Cohort.

Caroline M Stüven, Tina Herold, Paul Foerster … Benedikt Schworm
Read paper
OphthalmologyCohort study

Photodynamic therapy fully resolved subretinal fluid in about half of eyes.

Photodynamic Therapy in Central Serous Chorioretinopathy: Treatment Timing, Anatomical Response, and Recurrence in a Large Real-World Cohort.

Caroline M Stüven … Benedikt Schworm
Ophthalmology and therapy · 2026
Background

Central serous chorioretinopathy (central serous chorioretinopathy) is characterized by pathological accumulation of subretinal fluid (subretinal fluid), leading to visual impairment.

Purpose

This study aimed to identify predictors of treatment response in a large cohort of patients with central serous chorioretinopathy treated with photodynamic therapy.

Methods

In this retrospective, single-center study, clinical characteristics and treatment outcomes of patients with central serous chorioretinopathy undergoing photodynamic therapy were systematically analyzed.

n = 115 patients
51.3%
Results
51.3%
Photodynamic therapy cleared retinal fluid entirely in about half of eyes checked
n = 115 patients
More results

Mean visual acuity improved by -0.02 ± 0.22 logMAR (p = 0.0047).

Recurrence occurred in 30% of eyes after a mean of 1.1 ± 1.1 years.

A significant negative correlation was observed between time to photodynamic therapy and central retinal thickness reduction (r = -0.286, p = 0.001) but not with visual acuity (p = 0.76).

More results

Repeat photodynamic therapy, performed in 16 eyes, resulted in further significant central retinal thickness reduction (p = 0.008).

“
Conclusion · 1 of 2

Photodynamic therapy is effective in reducing subretinal fluid in central serous chorioretinopathy. Delayed treatment was associated with diminished anatomical response.

Conclusion · 2 of 2

Repeat photodynamic therapy may provide additional benefit in recurrent disease.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment